Annandale, NJ, United States of America

Jessica Liang

USPTO Granted Patents = 7 



Average Co-Inventor Count = 9.6

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Annandale, NJ (US) (2012 - 2018)
  • Annadale, NJ (US) (2022)

Company Filing History:


Years Active: 2012-2022

where 'Filed Patents' based on already Granted Patents

7 patents (USPTO):

Title: Jessica Liang: Innovator in Glycoside Derivatives

Introduction

Jessica Liang is a prominent inventor based in Annandale, NJ (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of glycoside derivatives. With a total of seven patents to her name, her work focuses on innovative solutions for treating diseases such as diabetes.

Latest Patents

Among her latest patents is a groundbreaking invention related to glycoside derivatives and their uses. This invention pertains to compounds represented by a specific formula, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), such as diabetes. The patent also outlines methods for treating these diseases and conditions, along with compositions for their treatment.

Career Highlights

Jessica has worked with notable companies in the pharmaceutical industry, including Novartis AG and Tyco Healthcare Group. Her experience in these organizations has allowed her to refine her expertise and contribute to significant advancements in healthcare.

Collaborations

Some of her coworkers include Gregory Raymond Bebernitz and Mark G. Bock, who have collaborated with her on various projects throughout her career.

Conclusion

Jessica Liang is a remarkable inventor whose work in glycoside derivatives has the potential to transform treatment options for diabetes and other related conditions. Her contributions to the field highlight the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…